Concise associated symptoms tracking scale: A brief self-report and clinician rating of symptoms associated with suicidality

Journal of Clinical Psychiatry

Volumn 72, Issue 6, 2011, Pages 765-774

  Trivedi, Madhukar H ^a   Wisniewski, Stephen R ^b   Morris, David W ^a   Fava, Maurizio ^c   Kurian, Benji T ^a   Gollan, Jackie K ^d   Nierenberg, Andrew A ^c   Warden, Diane ^a   Gaynes, Bradley N ^e   Luther, James F ^b   Rush, A John ^f  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^f NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; ESCITALOPRAM; FLUOXETINE; PAROXETINE; SERTRALINE;

ADULT; AGED; ANOREXIA; ANXIETY; ARTICLE; CONCISE ASSOCIATED SYMPTOMS TRACKING SCALE CLINICIAN RATING; CONCISE ASSOCIATED SYMPTOMS TRACKING SCALE SELF REPORT; CONTROLLED STUDY; CRONBACH ALPHA COEFFICIENT; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; FATIGUE; FEMALE; GUILT; HEALTH CARE PERSONNEL; HUMAN; INSOMNIA; IRRITABILITY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MANIA; MENTAL CONCENTRATION; MULTICENTER STUDY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OPEN STUDY; OUTPATIENT; PANIC; PATIENT MONITORING; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; PSYCHOMETRY; PSYCHOMOTOR RETARDATION; RESTLESSNESS; SELF CONCEPT; SELF REPORT; SLEEP DISORDER; SUICIDAL BEHAVIOR; SUICIDAL IDEATION; SYMPTOM; WEIGHT CHANGE;

ADOLESCENT; ADULT; AGED; DEPRESSIVE DISORDER, MAJOR; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; REPRODUCIBILITY OF RESULTS; SELF REPORT; SEROTONIN UPTAKE INHIBITORS; SUICIDAL IDEATION; SUICIDE; YOUNG ADULT;

EID: 79959599518     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.11m06840     Document Type: Article

References (41)

1. Hansen L, Wilkinson DG. Drug induced akathisia, suicidal ideation and its treatment in the elderly. Int J Geriatr Psychiatry. 2001;16(2):231-233. doi:10.102/109-16(20102)16:2〈231:AID-GPS303〉3.0.CO;2-Y PubMed (Pubitemid 32166318)
2. Healy D. Lines of evidence on the risks of suicide with selective serotonin reuptake inhibitors. Psychother Psychosom. 2003;72(2):71-79. doi:10.159/068691 PubMed (Pubitemid 36302475)
3. Mann JJ, Kapur S. The emergence of suicidal ideation and behavior during antidepressant pharmacotherapy. Arch Gen Psychiatry. 1991;48(11):1027-1033. PubMed
4. Moynihan R. FDA advisory panel calls for suicide warnings over new antidepressants. BMJ. 2004;328(7435):303. doi:10.136/bmj.328.7435.303-a PubMed
5. Adler LA, Angrist BM. Paroxetine and akathisia. Biol Psychiatry. 1995;37(5):336-337. doi:10.1016/06-323(94)0158-Y PubMed
6. Chong SA, Tan CH. Fluvoxamine and akathisia. J Clin Psychopharmacol. 1996;16(4):334-335. doi:10.1097/04714-196080-013 PubMed
7. Teicher MH, Glod C, Cole JO. Emergence of intense suicidal preoccupation during fluoxetine treatment. (see comments) Am J Psychiatry. 1990;147(2):207-210. PubMed
8. Teicher MH, Glod CA, Cole JO. Antidepressant drugs and the emergence of suicidal tendencies. (Review) Drug Saf. 1993;8(3):186-212. doi:10.2165/02018- 19308030-02 PubMed (Pubitemid 23123065)
9. Labeling change request letter for antidepressant medications. US Food and Drug Administration. http://www.fda.gov/Drugs/DrugSafety/ InformationbyDrugClass/ucm096352.htm. Updated: 2009. Accessed April 26, 2011.
10. FDA Public Health Advisory. Suicidality in adults being treated with antidepressant medications. US Food and Drug Administration. http://www.fda.gov/downloads/Drugs/DrugSafety/InformationbyDrugClass/UCM173233. pdf. Access from original page at: http://www.fda.gov/Drugs/DrugSafety/ InformationbyDrugClass/ucm096273.htm. Updated 2010. Accessed March 22, 2011.
11. Harada T, Sakamoto K, Ishigooka J. Incidence and predictors of activation syndrome induced by antidepressants. Depress Anxiety. 2008;25(12):1014-1019. doi:10.102/da.20438 PubMed
12. Akiskal HS, Benazzi F, Perugi G, et al. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy. J Affect Disord. 2005;85(3):245-258. doi:10.1016/j.jad.204.12.04 PubMed (Pubitemid 40386508)
13. Chun BJ, Dunner DL. A review of antidepressant-induced hypomania in major depression: suggestions for DSM-V. Bipolar Disord. 2004;6(1):32-42. doi:10.1046/j.139-5618.203.084.x PubMed (Pubitemid 38256502)
14. Miller IW, Norman WH, Bishop SB, et al. The Modified Scale for Suicidal Ideation: reliability and validity. J Consult Clin Psychol. 1986;54(5):724-725. doi:10.1037/02-06X.54.5.724 PubMed
15. Posner K, Oquendo MA, Gould M, et al. Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants. Am J Psychiatry. 2007;164(7):1035-1043. doi:10.176/api.ajp.164.7.1035 PubMed (Pubitemid 47121392)
16. Altman EG, Hedeker DR, Janicak PG, et al. The Clinician-Administered Rating Scale for Mania (CARS-M): development, reliability, and validity. Biol Psychiatry. 1994;36(2):124-134. doi:10.1016/06-323(94)9193-2 PubMed (Pubitemid 124009221)
17. Barnes TR. The Barnes Akathisia Rating Scale - revisited. J Psychopharmacol. 2003;17(4):365-370. doi:10.17/02698103174013 PubMed (Pubitemid 38076330)
18. Barratt ES, Stanford MS. Impulsiveness. New York, NY: Wiley; 1995.
19. Beck AT, Epstein N, Brown G, et al. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988;56(6):893-897. doi:10.1037/02-06X.56.6.893 PubMed (Pubitemid 19008360)
20. Buss AH, Durkee A. An inventory for assessing different kinds of hostility. J Consult Psychol. 1957;21(4):343-349. doi:10.1037/h04690 PubMed
21. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56-62. doi:10.136/jnp.23.1.56 PubMed
22. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967;6(4):278-296. PubMed
23. Lecrubier Y, Braconnier A, Said S, et al. The impulsivity rating scale (IRS): preliminary results. Eur Psychiatry. 1995;10(7):331-338. doi:10.1016/0924-938(96)803-6 PubMed (Pubitemid 26009149)
24. Levine J, Schooler NR. SAFTEE: a technique for the systematic assessment of side effects in clinical trials. Psychopharmacol Bull. 1986;22(2):343-381. PubMed
25. Osman A, Gutierrez PM, Kopper BA, et al. The positive and negative suicide ideation inventory: development and validation. Psychol Rep. 1998;82(3, Pt 1):783-793. doi:10.246/PR0.82.3.783-793 PubMed (Pubitemid 128455905)
26. Rush AJ, Giles DE, Schlesser MA, et al. The Inventory for Depressive Symptomatology (IDS): preliminary findings. Psychiatry Res. 1986;18(1):65-87. doi:10.1016/0165-1781(86)9060-0 PubMed (Pubitemid 16085767)
27. Rush AJ, Gullion CM, Basco MR, et al. The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychol Med. 1996;26(3):477-486. doi:10.1017/S0329170358 PubMed (Pubitemid 26142491)
28. Rush AJ, Carmody TJ, Reimitz PE. The Inventory of Depressive Symptomatology (IDS): clinician (IDS-C) and self-report (IDS-SR) ratings of depressive symptoms. Int J Methods Psychiatr Res. 2000;9(2):45-59. doi:10.102/mpr.79
29. Rush AJ, Trivedi MH, Ibrahim HM, et al. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry. 2003;54(5):573-583 [Erratum p 585]. PubMed
30. Sangha O, Stucki G, Liang MH, et al. The Self-Administered Comorbidity Questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheum. 2003;49(2):156-163. doi:10.102/art.1093 PubMed (Pubitemid 36418272)
31. Wisniewski SR, Rush AJ, Balasubramani GK, et al; for the STAR*D Investigators. Self-rated global measure of the frequency, intensity, and burden of side effects. J Psychiatr Pract. 2006;12(2):71-79. doi:10.1097/0131746- 206030-02 PubMed (Pubitemid 44284089)
32. Zimmerman M, Mattia JI. The reliability and validity of a screening Questionnaire for 13 DSM-IV Axis I disorders (the Psychiatric Diagnostic Screening Questionnaire) in psychiatric outpatients. J Clin Psychiatry. 1999;60(10):677-683. doi:10.408/JCP.v60n106 PubMed (Pubitemid 29503648)
33. Zimmerman M, Mattia JI. A self-report scale to help make psychiatric diagnoses: the Psychiatric Diagnostic Screening Questionnaire. Arch Gen Psychiatry. 2001;58(8):787-794. doi:10.101/archpsyc.58.8.787 PubMed (Pubitemid 32717805)
34. Zimmerman M, Mattia JI. The Psychiatric Diagnostic Screening Questionnaire: development, reliability and validity. Compr Psychiatry. 2001;42(3):175-189. doi:10.1053/comp.201.23126 PubMed (Pubitemid 32410920)
35. Trivedi MH, Rush AJ, Wisniewski SR, et al; STAR*D Study Team. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry. 2006;163(1):28-40. doi:10.176/api.ajp.163.1.28 PubMed
36. Trivedi MH, Daly EJ. Measurement-based care for refractory depression: a clinical decision support model for clinical research and practice. Drug Alcohol Depend. 2007;88(suppl 2):S61-S71. doi:10.1016/j.drugalcdep.207.01.07 PubMed (Pubitemid 46528065)
37. Trivedi MH, Rush AJ, Gaynes BN, et al. Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR(*)D measurement-based care. Neuropsychopharmacology. 2007;32(12):2479-2489. doi:10.1038/sj.np.1301390 PubMed
38. Trivedi MH, Rush AJ, Ibrahim HM, et al. The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychol Med. 2004;34(1):73-82. doi:10.1017/ S032917030107 PubMed (Pubitemid 38139442)
39. Fava M, Alpert JE, Carmin CN, et al. Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*D. Psychol Med. 2004;34(7):1299-1308. doi:10.1017/S0329170402612 PubMed
40. Fava M, Rush AJ, Alpert JE, et al. What clinical and symptom features and comorbid disorders characterize outpatients with anxious major depressive disorder: a replication and extension. Can J Psychiatry. 2006;51(13):823-835. PubMed
41. Fava M, Rosenbaum JF, Hoog SL, et al. Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression. J Affect Disord. 2000;59(2):119-126. doi:10.1016/S0165 (Pubitemid 30317428)